CN Stock MarketDetailed Quotes

002332 Zhejiang Xianju Pharmaceutical

Watchlist
  • 11.85
  • -0.04-0.34%
Market Closed Aug 23 15:00 CST
11.72BMarket Cap20.19P/E (TTM)

Zhejiang Xianju Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
8.42%1.04B
-5.85%4.12B
-6.24%3.24B
-4.93%2.12B
-8.75%957.29M
0.52%4.38B
4.09%3.45B
3.96%2.23B
4.76%1.05B
8.42%4.36B
Operating revenue
8.42%1.04B
-5.85%4.12B
-6.24%3.24B
-4.93%2.12B
-8.75%957.29M
0.52%4.38B
4.09%3.45B
3.96%2.23B
4.76%1.05B
8.42%4.36B
Other operating revenue
----
104.30%43.96M
----
11.33%14.17M
----
-4.18%21.52M
----
23.78%12.73M
----
32.81%22.46M
Total operating cost
9.84%872.35M
-4.22%3.49B
-5.18%2.68B
-5.21%1.74B
-11.65%794.2M
-0.72%3.64B
2.69%2.83B
2.65%1.84B
4.44%898.97M
6.22%3.67B
Operating cost
2.14%465.93M
6.02%1.94B
7.38%1.58B
9.81%1.02B
3.61%456.18M
0.26%1.83B
8.36%1.47B
4.16%931.93M
2.04%440.3M
2.53%1.83B
Operating tax surcharges
3.94%5.59M
-4.35%36.87M
-10.60%24.95M
-9.93%16.97M
-19.14%5.38M
-0.49%38.54M
-4.72%27.9M
3.00%18.84M
8.50%6.65M
12.51%38.73M
Operating expense
15.65%255.8M
-21.60%989.98M
-27.39%726.84M
-29.63%459.3M
-30.09%221.19M
-1.33%1.26B
7.14%1B
12.83%652.7M
15.78%316.38M
16.82%1.28B
Administration expense
15.19%82.39M
4.31%281.23M
16.77%232.56M
10.19%158.75M
-1.19%71.53M
-3.77%269.6M
-23.48%199.17M
-21.02%144.07M
-19.69%72.39M
12.88%280.18M
Financial expense
-315.93%-5.86M
16.45%-22.32M
-0.07%-19.6M
-45.10%-9.33M
-123.96%-1.41M
-40,784.61%-26.71M
-209.62%-19.59M
-136.68%-6.43M
-25.35%5.88M
-99.92%65.65K
-Interest expense (Financial expense)
-31.17%596.19K
-46.47%3.37M
-64.95%2.57M
-71.38%1.75M
-75.00%866.15K
-72.78%6.29M
-55.48%7.34M
-53.25%6.11M
-41.46%3.46M
-53.07%23.1M
-Interest Income (Financial expense)
-2.08%-7.31M
-40.79%-38.28M
-215.12%-28.45M
-203.06%-18.59M
-144.46%-7.16M
-86.12%-27.19M
12.42%-9.03M
24.72%-6.14M
-26.74%-2.93M
-65.18%-14.61M
Research and development
65.73%68.51M
-2.16%261M
-7.54%139.46M
-3.79%93.4M
-27.95%41.34M
9.61%266.77M
-3.87%150.82M
-2.18%97.07M
10.64%57.37M
16.79%243.37M
Credit Impairment Loss
31.93%-5.99M
154.33%5.04M
49.88%-6.78M
7.96%-11.43M
-47.36%-8.8M
-178.97%-9.27M
-72.83%-13.54M
-76.97%-12.42M
-67.26%-5.97M
13.19%11.74M
Asset Impairment Loss
----
11.21%-28.56M
-69.24%-27.49M
-48.01%-27.52M
----
-57.54%-32.16M
28.74%-16.25M
18.56%-18.59M
----
-12.03%-20.42M
Other net revenue
291.21%18.41M
-90.94%12.92M
-128.90%-9.92M
-197.43%-22.13M
-364.16%-9.63M
99.70%142.54M
945.90%34.31M
262.14%22.71M
83.87%3.64M
113.82%71.38M
Fair value change income
----
----
----
----
----
----
--3.87M
--2.32M
----
--641.67K
Invest income
1,677.20%18.68M
-118.18%-8.97M
-70.86%11.39M
-75.58%8.64M
-133.60%-1.18M
72.67%49.35M
213.96%39.08M
312.47%35.36M
30.94%3.52M
366.74%28.58M
-Including: Investment income associates
521.81%5M
-105.35%-7.95M
112.29%11.39M
108.48%8.64M
-133.60%-1.18M
-143.32%-3.87M
-38.36%5.36M
-43.05%4.14M
30.94%3.52M
74.91%8.94M
Asset deal income
104.33%64.29K
-101.61%-1.48M
-3,866.88%-1.71M
-3,936.07%-1.74M
---1.48M
531.50%91.62M
-99.18%45.3K
231.85%45.35K
----
2,050.19%14.51M
Other revenue
206.70%5.66M
9.05%46.89M
-30.44%14.68M
-37.99%9.92M
-69.73%1.84M
18.40%43M
145.56%21.1M
119.18%16M
110.90%6.09M
1.30%36.32M
Operating profit
19.89%183.98M
-26.42%646.46M
-17.19%545.1M
-14.31%353.52M
-0.16%153.46M
15.81%878.6M
17.92%658.24M
21.88%412.54M
7.79%153.7M
27.03%758.65M
Add:Non operating Income
9.58%1.23M
191.35%4.32M
-36.69%3.55M
3,381.62%2.19M
375.81%1.12M
112.34%1.48M
57.09%5.61M
-88.88%63.04K
-71.86%235.68K
-97.68%697.82K
Less:Non operating expense
243.30%3.08M
11.10%9.1M
-43.40%5.36M
-50.46%4.16M
-83.90%896.75K
-72.23%8.19M
5.71%9.48M
100.51%8.39M
318.97%5.57M
389.25%29.49M
Total profit
18.51%182.13M
-26.40%641.68M
-16.97%543.29M
-13.03%351.56M
3.58%153.68M
19.46%871.89M
18.37%654.37M
20.71%404.22M
4.41%148.36M
17.48%729.87M
Less:Income tax cost
5.05%25.61M
-36.09%79.56M
-41.35%71.34M
-37.19%50.59M
-7.18%24.38M
14.63%124.49M
32.52%121.63M
34.49%80.56M
-10.97%26.27M
17.73%108.6M
Net profit
21.05%156.52M
-24.79%562.12M
-11.41%471.95M
-7.01%300.97M
5.90%129.3M
20.30%747.4M
15.55%532.73M
17.70%323.66M
8.44%122.09M
17.44%621.26M
Net profit from continuing operation
21.05%156.52M
-24.79%562.12M
-11.41%471.95M
-7.01%300.97M
5.90%129.3M
20.30%747.4M
15.55%532.73M
17.70%323.66M
8.44%122.09M
17.44%621.26M
Less:Minority Profit
241.42%5.39M
52.08%-965.01K
-90.05%350.04K
88.67%-842.4K
32.11%-3.81M
-204.03%-2.01M
93.66%3.52M
-893.90%-7.43M
-382.71%-5.62M
-92.09%1.94M
Net profit of parent company owners
13.53%151.12M
-24.86%563.08M
-10.89%471.6M
-8.84%301.81M
4.23%133.11M
21.00%749.41M
15.24%529.21M
20.82%331.09M
15.47%127.71M
22.76%619.33M
Earning per share
Basic earning per share
15.38%0.15
-24.76%0.57
-10.90%0.4767
-6.06%0.31
0.00%0.13
21.00%0.7576
15.25%0.535
17.86%0.33
18.18%0.13
13.84%0.6261
Diluted earning per share
15.38%0.15
-24.76%0.57
-10.90%0.4767
-6.06%0.31
0.00%0.13
21.00%0.7576
15.25%0.535
17.86%0.33
18.18%0.13
13.84%0.6261
Other composite income
-308.97%-30.17M
106.59%44.87M
205.70%25.34M
406.28%70.36M
206.96%14.44M
125.72%21.72M
32.32%-23.97M
-8.79%-22.97M
31.08%-13.5M
-223.75%-84.44M
Other composite income of parent company owners
-308.97%-30.17M
106.59%44.87M
205.70%25.34M
406.28%70.36M
206.96%14.44M
125.72%21.72M
32.32%-23.97M
-8.79%-22.97M
31.08%-13.5M
-223.75%-84.44M
Total composite income
-12.10%126.34M
-21.08%606.99M
-2.26%497.29M
23.49%371.32M
32.36%143.74M
43.27%769.12M
19.53%508.76M
18.44%300.69M
16.77%108.6M
-10.12%536.82M
Total composite income of parent company owners
-18.03%120.95M
-21.16%607.95M
-1.64%496.94M
20.79%372.17M
29.19%147.55M
44.17%771.13M
19.21%505.24M
21.82%308.12M
25.49%114.21M
-6.61%534.89M
Total composite income of minority owners
241.42%5.39M
52.08%-965.01K
-90.05%350.04K
88.67%-842.4K
32.11%-3.81M
-204.03%-2.01M
93.66%3.52M
-893.90%-7.43M
-382.71%-5.62M
-92.09%1.94M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 8.42%1.04B-5.85%4.12B-6.24%3.24B-4.93%2.12B-8.75%957.29M0.52%4.38B4.09%3.45B3.96%2.23B4.76%1.05B8.42%4.36B
Operating revenue 8.42%1.04B-5.85%4.12B-6.24%3.24B-4.93%2.12B-8.75%957.29M0.52%4.38B4.09%3.45B3.96%2.23B4.76%1.05B8.42%4.36B
Other operating revenue ----104.30%43.96M----11.33%14.17M-----4.18%21.52M----23.78%12.73M----32.81%22.46M
Total operating cost 9.84%872.35M-4.22%3.49B-5.18%2.68B-5.21%1.74B-11.65%794.2M-0.72%3.64B2.69%2.83B2.65%1.84B4.44%898.97M6.22%3.67B
Operating cost 2.14%465.93M6.02%1.94B7.38%1.58B9.81%1.02B3.61%456.18M0.26%1.83B8.36%1.47B4.16%931.93M2.04%440.3M2.53%1.83B
Operating tax surcharges 3.94%5.59M-4.35%36.87M-10.60%24.95M-9.93%16.97M-19.14%5.38M-0.49%38.54M-4.72%27.9M3.00%18.84M8.50%6.65M12.51%38.73M
Operating expense 15.65%255.8M-21.60%989.98M-27.39%726.84M-29.63%459.3M-30.09%221.19M-1.33%1.26B7.14%1B12.83%652.7M15.78%316.38M16.82%1.28B
Administration expense 15.19%82.39M4.31%281.23M16.77%232.56M10.19%158.75M-1.19%71.53M-3.77%269.6M-23.48%199.17M-21.02%144.07M-19.69%72.39M12.88%280.18M
Financial expense -315.93%-5.86M16.45%-22.32M-0.07%-19.6M-45.10%-9.33M-123.96%-1.41M-40,784.61%-26.71M-209.62%-19.59M-136.68%-6.43M-25.35%5.88M-99.92%65.65K
-Interest expense (Financial expense) -31.17%596.19K-46.47%3.37M-64.95%2.57M-71.38%1.75M-75.00%866.15K-72.78%6.29M-55.48%7.34M-53.25%6.11M-41.46%3.46M-53.07%23.1M
-Interest Income (Financial expense) -2.08%-7.31M-40.79%-38.28M-215.12%-28.45M-203.06%-18.59M-144.46%-7.16M-86.12%-27.19M12.42%-9.03M24.72%-6.14M-26.74%-2.93M-65.18%-14.61M
Research and development 65.73%68.51M-2.16%261M-7.54%139.46M-3.79%93.4M-27.95%41.34M9.61%266.77M-3.87%150.82M-2.18%97.07M10.64%57.37M16.79%243.37M
Credit Impairment Loss 31.93%-5.99M154.33%5.04M49.88%-6.78M7.96%-11.43M-47.36%-8.8M-178.97%-9.27M-72.83%-13.54M-76.97%-12.42M-67.26%-5.97M13.19%11.74M
Asset Impairment Loss ----11.21%-28.56M-69.24%-27.49M-48.01%-27.52M-----57.54%-32.16M28.74%-16.25M18.56%-18.59M-----12.03%-20.42M
Other net revenue 291.21%18.41M-90.94%12.92M-128.90%-9.92M-197.43%-22.13M-364.16%-9.63M99.70%142.54M945.90%34.31M262.14%22.71M83.87%3.64M113.82%71.38M
Fair value change income --------------------------3.87M--2.32M------641.67K
Invest income 1,677.20%18.68M-118.18%-8.97M-70.86%11.39M-75.58%8.64M-133.60%-1.18M72.67%49.35M213.96%39.08M312.47%35.36M30.94%3.52M366.74%28.58M
-Including: Investment income associates 521.81%5M-105.35%-7.95M112.29%11.39M108.48%8.64M-133.60%-1.18M-143.32%-3.87M-38.36%5.36M-43.05%4.14M30.94%3.52M74.91%8.94M
Asset deal income 104.33%64.29K-101.61%-1.48M-3,866.88%-1.71M-3,936.07%-1.74M---1.48M531.50%91.62M-99.18%45.3K231.85%45.35K----2,050.19%14.51M
Other revenue 206.70%5.66M9.05%46.89M-30.44%14.68M-37.99%9.92M-69.73%1.84M18.40%43M145.56%21.1M119.18%16M110.90%6.09M1.30%36.32M
Operating profit 19.89%183.98M-26.42%646.46M-17.19%545.1M-14.31%353.52M-0.16%153.46M15.81%878.6M17.92%658.24M21.88%412.54M7.79%153.7M27.03%758.65M
Add:Non operating Income 9.58%1.23M191.35%4.32M-36.69%3.55M3,381.62%2.19M375.81%1.12M112.34%1.48M57.09%5.61M-88.88%63.04K-71.86%235.68K-97.68%697.82K
Less:Non operating expense 243.30%3.08M11.10%9.1M-43.40%5.36M-50.46%4.16M-83.90%896.75K-72.23%8.19M5.71%9.48M100.51%8.39M318.97%5.57M389.25%29.49M
Total profit 18.51%182.13M-26.40%641.68M-16.97%543.29M-13.03%351.56M3.58%153.68M19.46%871.89M18.37%654.37M20.71%404.22M4.41%148.36M17.48%729.87M
Less:Income tax cost 5.05%25.61M-36.09%79.56M-41.35%71.34M-37.19%50.59M-7.18%24.38M14.63%124.49M32.52%121.63M34.49%80.56M-10.97%26.27M17.73%108.6M
Net profit 21.05%156.52M-24.79%562.12M-11.41%471.95M-7.01%300.97M5.90%129.3M20.30%747.4M15.55%532.73M17.70%323.66M8.44%122.09M17.44%621.26M
Net profit from continuing operation 21.05%156.52M-24.79%562.12M-11.41%471.95M-7.01%300.97M5.90%129.3M20.30%747.4M15.55%532.73M17.70%323.66M8.44%122.09M17.44%621.26M
Less:Minority Profit 241.42%5.39M52.08%-965.01K-90.05%350.04K88.67%-842.4K32.11%-3.81M-204.03%-2.01M93.66%3.52M-893.90%-7.43M-382.71%-5.62M-92.09%1.94M
Net profit of parent company owners 13.53%151.12M-24.86%563.08M-10.89%471.6M-8.84%301.81M4.23%133.11M21.00%749.41M15.24%529.21M20.82%331.09M15.47%127.71M22.76%619.33M
Earning per share
Basic earning per share 15.38%0.15-24.76%0.57-10.90%0.4767-6.06%0.310.00%0.1321.00%0.757615.25%0.53517.86%0.3318.18%0.1313.84%0.6261
Diluted earning per share 15.38%0.15-24.76%0.57-10.90%0.4767-6.06%0.310.00%0.1321.00%0.757615.25%0.53517.86%0.3318.18%0.1313.84%0.6261
Other composite income -308.97%-30.17M106.59%44.87M205.70%25.34M406.28%70.36M206.96%14.44M125.72%21.72M32.32%-23.97M-8.79%-22.97M31.08%-13.5M-223.75%-84.44M
Other composite income of parent company owners -308.97%-30.17M106.59%44.87M205.70%25.34M406.28%70.36M206.96%14.44M125.72%21.72M32.32%-23.97M-8.79%-22.97M31.08%-13.5M-223.75%-84.44M
Total composite income -12.10%126.34M-21.08%606.99M-2.26%497.29M23.49%371.32M32.36%143.74M43.27%769.12M19.53%508.76M18.44%300.69M16.77%108.6M-10.12%536.82M
Total composite income of parent company owners -18.03%120.95M-21.16%607.95M-1.64%496.94M20.79%372.17M29.19%147.55M44.17%771.13M19.21%505.24M21.82%308.12M25.49%114.21M-6.61%534.89M
Total composite income of minority owners 241.42%5.39M52.08%-965.01K-90.05%350.04K88.67%-842.4K32.11%-3.81M-204.03%-2.01M93.66%3.52M-893.90%-7.43M-382.71%-5.62M-92.09%1.94M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg